GCC Pharmaceutical Logistics Market to Reach USD 2.78 Billion by 2032, Growing at a CAGR of Around 6.7% During 2026–2032

The GCC Pharmaceutical Logistics Market was valued at approximately USD 2.6 billion in 2025 and is projected to grow from USD 2.78 billion in 2026 to nearly USD 4.10 billion by 2032, registering a CAGR of around 6.7% during 2026–2032. Market expansion is being driven by rising pharmaceutical consumption, increasing localization of drug manufacturing, and growing demand for compliant pharmaceutical storage and distribution infrastructure across GCC countries. The region’s continued dependence on imported pharmaceutical products is further accelerating demand for customs-integrated logistics and temperature-controlled transportation systems.

Saudi Arabia continues to represent the largest regional market, supported by large-scale pharmaceutical spending, Vision 2030 localization initiatives, and expanding domestic drug manufacturing capabilities. The Kingdom’s Healthcare Sector Transformation Program and centralized procurement activities through NUPCO are further strengthening pharmaceutical supply-chain infrastructure while increasing demand for compliant warehousing, inventory management, and nationwide pharmaceutical distribution services. Moreover, the country’s broader logistics modernization strategy is accelerating infrastructure development across healthcare-focused supply-chain networks.

The GCC pharmaceutical logistics market is primarily driven by road transportation, which accounted for the largest share of the market in 2026, owing to its extensive regional distribution network and cost-effective delivery capabilities. Refrigerated storage is expected to witness the fastest growth during 2026–2032, supported by increasing demand for biologics, vaccines, and other temperature-sensitive pharmaceuticals. Saudi Arabia dominated the market with approximately 50% of the regional share, driven by its large healthcare sector, growing pharmaceutical demand, and ongoing investments in healthcare and logistics infrastructure, as stated in the recent report “GCC Pharmaceuticals Logistics Market Analysis, 2026”.

GCC Pharmaceutical Logistics Market Highlights

The GCC Pharmaceutical Logistics Market was valued at approximately USD 2.78 billion in 2026 and is projected to reach nearly USD 4.10 billion by 2032.
The market is expected to register a CAGR of around 6.7% during 2026–2032, supported by rising pharmaceutical consumption, biologics distribution, and expanding cold-chain infrastructure investments.
By Mode of Transport, Road Transportation dominated the GCC Pharmaceutical Logistics Market in 2026, accounting for approximately 65–70% of the total market share, driven by extensive domestic distribution networks, growing hospital and pharmacy deliveries, and the cost-effectiveness of road-based pharmaceutical transportation across GCC countries.
By Storage Type, Refrigerated Storage held the largest share of approximately 55–60% in 2026 and is also expected to register the fastest growth during 2026–2032, supported by increasing demand for biologics, vaccines, insulin products, and other temperature-sensitive pharmaceuticals requiring controlled storage environments.
Saudi Arabia dominated the GCC Pharmaceutical Logistics Market in 2026, accounting for approximately 50% of the regional market share, driven by its large population base, expanding pharmaceutical manufacturing sector, growing healthcare expenditure, and ongoing investments in healthcare infrastructure, cold-chain facilities, and supply-chain modernization initiatives.
The GCC pharmaceutical logistics industry remains moderately consolidated, with major players including Kuehne+Nagel Middle East, DHL Supply Chain, Aramex, Agility, and DB Schenker collectively accounting for a significant regional market share.